U.S. FDA grants approval to complete enrollment in EndoQuest’s ongoing PARADIGM Trial following the clinical study’s favorable interim safety review Dr. Eric Haas performing the PARADIGM Trial’s first ...
EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a robotic endoluminal system for gastrointestinal procedures. The ...
Fundación Hospital de Calahorra, La Rioja, Spain. Service of Digestive Diseases, Hospital Clínico Lozano Blesa, Zaragoza, Spain&The Centro de Investigación Biomédica en Red, Barcelona, Spain. Service ...
When Senate Bill 5041 takes effect in January 2026, Washington state will become one of the few states allowing striking workers to collect unemployment insurance (UI) benefits. I’ve written ...
Cannulating protruding or pendulous type 3 papilla presents a higher level of difficulty in ERCP. Although pre-cutting papillotomy is a viable strategy, it is not without challenges. To overcome this ...
CENTER VALLEY, Pa., May 22, 2025 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today the ...
The MarketWatch News Department was not involved in the creation of this content. CENTER VALLEY, Pa., May 22, 2025 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results